secwatch.observer — SEC 8-K summary
======================================

Issuer:     Molecular Templates, Inc. (—)
CIK:        0001183765
Form:       8-K
Filed at:   2024-04-12T23:59:59+00:00
Accession:  0001193125-24-094733
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 2.05, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Molecular Templates cuts 30% of workforce; CMO Maurizio Voi to depart April 30
------------------------------------------------------------------------------

- Board approved reduction in force of ~30% to extend resources for clinical studies of MT-6402, MT-8421, MT-0169.
- Estimated pre-tax charges of ~$0.1M for legal fees and termination costs; expected completion by end of April 2024.
- Chief Medical Officer Maurizio Voi, M.D. will cease role effective April 30, 2024 in connection with the reduction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1183765/000119312524094733/0001193125-24-094733-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1183765/000119312524094733/d827658d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-094733

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer